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Abstract
Introduction
Liver diseases account for two million deaths per year worldwide, half of which are attributed to
complications of cirrhosis. Liver conditions have wide-ranging serological findings and imaging
appearances and may require biopsy for a definitive diagnosis. Despite ultrasound (US)
guidance, liver biopsy is an invasive procedure and the expected benefit must outweigh risks
involved. 
Objective 
The purpose of the audit was to calculate complication rates of US-guided liver biopsy and
summarize institutional data pertaining to the procedure. 
Materials and Methods
The audit was performed at Aga Khan University Hospital, Karachi, Pakistan. All consecutive
patients undergoing liver biopsy from February 2017 - February 2018 were included. Medical
records of patients were reviewed for complications of liver biopsy. 
Results
The study population consisted of 157 adult and 21 pediatric patients. Complications were
encountered in nine patients (5%), minor complications in seven (4%) and major complications
in two (1.1%). Among the minor complications, haematoma formation was noted in four
patients (2.2%), minor abdominal pain in two patients (1.1%), and minor hemorrhage during
the procedure in one patient (0.5%). Minor complications were seen more frequently in
pediatric (14%) patients as compared to adults (3.8%). One patient developed a major
hemorrhage (> 2 g/dl drop in hemoglobin (Hb)), and another patient developed severe
vasovagal hypotension. There was no mortality in the study population resulting from
complications of the liver biopsy. The audit standards set were met for all parameters, except
major hemorrhage (< 0.5%) which was narrowly missed (0.56%).
Conclusion
US-guided liver biopsy at our institution has a good safety profile with complication rates
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Introduction
Liver diseases account for approximately two million deaths per year worldwide, half of which
are attributed to complications of cirrhosis. Cirrhotic liver disease is 11th and liver cancer is
16th most common cause of death globally [1-2]. Liver diseases are wide-ranging with varying
clinical, serological, and imaging findings. Although serological markers and imaging are
routinely ordered in the evaluation of liver diseases, these are no substitute for a liver biopsy
which provides a definitive diagnosis [3].
A liver biopsy procedure is preferably performed with ultrasound (US) guidance in
which multiple passes may be acquired to obtain a diagnostic sample. US-guided liver biopsy is
a cost-effective procedure owing to its high specimen adequacy rate and low complication
rate [4]. Despite real-time imaging guidance with US, a liver biopsy is an invasive, non-
vascular interventional procedure, and therefore, the benefits of biopsy must outweigh the
risks of complications [5].
Data regarding the safety profile of liver biopsy in local healthcare institutions is lacking. The
objective of our study was to determine the safety profile of liver biopsy procedures at our
institution. 
Materials And Methods
The audit was performed in the Department of Radiology at the Aga Khan University Hospital,
Pakistan. The nature of the study was retrospective and was approved by the institutional
ethics review committee with a waiver of consent. All consecutive patients undergoing US-
guided liver biopsy during the study period of February 2017 - February 2018 were
included. Data were retrieved using the radiology information system (RIS), hospital
information system (HIS) and picture archiving and communications system (PACS). Audit
standards were set according to the findings of the United Kingdom (UK) National Audit
Evaluating Image-guided or Image-assisted Liver Biopsy, Parts I and II, as listed in Table 1 [6-
7].
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Audit Standards
Completed consent form 100%
Documented post-procedural instructions 100%
Specimen adequacy > 98%
Normal baseline coagulation 100%
Minor pain < 30%
Significant hemorrhage < 0.5%
Vasovagal hypotension < 3%
Severe pain < 3%
Puncture of another organ < 0.1%
Death < 0.1%
Hemobilia < 0.1%
TABLE 1: Audit Standards
Data items that were collected are listed in Table 2. Complications related to liver biopsy were
broadly classified into major and minor complications. Major complications included
significant hemorrhage (> 2 g/dl), severe hypotension, organ perforation, hemobilia, and death.
The minor complications included minor pain, hypotension, and minor hemorrhage [7]. 
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Data items collected
Patient demographics
Referrer
Clinical information
Coagulation profile
Location of biopsy
Needle size
History of repeat biopsy
Complication(s) documented
Postprocedure FAST
Histopathology report
Documented post-procedural instructions
TABLE 2: Data Items Collected
FAST: focused assessment with sonography for trauma
A summary of departmental practices is listed in Table 3. 
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Summary of departmental practices
Prior imaging is reviewed by the radiologist at the time of appointment and prior to biopsy
Coagulation profile is obtained as per departmental policy for invasive procedures (INR ≤ 1.5 and platelet count ≥  75 ×
109/ L, within the same week)
Informed consent obtained as per hospital policy
Sedation required in all pediatric patients
Pre-procedure sonographic evaluation for the presence of ascites, approach determination, and pre-marking of the
biopsy site. Procedure postponed if ascites is present
Determination of the size of Tru-Cut® biopsy needle is made by the performing radiologist
Biopsy is performed using a coaxial technique or non-coaxial technique and multiple passes may be made
Post-procedure, patients are observed for 4 hours with regular vitals monitoring. Appropriate analgesia is given for pain
Post-procedure FAST is performed within 2 hours to assess for hemoperitoneum
Stable patients with no major pain and without hemoperitoneum are discharged with instructions
TABLE 3: Summary of Departmental Practices
Tru-Cut® biopsy needle (Merit Medical Systems, Jordan, UT)
FAST: focused assessment with sonography for trauma; INR: international normalized ratio
Data were entered into a worksheet (Microsoft® Office Excel 2013; Microsoft® Corp., Redmond,
WA) and percentage frequency of major and minor complications were calculated.
Results
The final study population consisted of 178 patients. An even gender distribution was noted,
with 48.9% male and 51% female patients. The mean age of the study population was 47.63
years (range: 1 - 82 years). 
Complications were encountered in nine (5%) patients, minor in seven patients (4%) and major
in two patients (1.1%). Of the minor complications, hematoma formation was noted in four
patients (2.2%), minor abdominal pain in two patients (1.1%), and minor haemorrhage during
the procedure in one patient (0.5%). In patients who had major complications, one patient had
a significant intraperitoneal hemorrhage (> 2 g/dl drop in hemoglobin) and one patient
developed severe vasovagal hypotension. These are summarized in Table 4. 
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Complication Frequency (%)
Overall 5 (9/178)
Minor 3.9 (7/178)
Major 1.1 (2/178)
TABLE 4: Post-biopsy Complications
There was no mortality recorded in the study population resulting from complications of the
biopsy procedure.
Compared to the adult population, the complication rate was slightly higher in pediatric
patients (14%) as compared to adults (3.8%). These were, however, minor complications and no
major complication was encountered in any pediatric patient. 
A targeted biopsy was performed in 164 patients (92%), with right lobe lesions biopsied in 157
patients and left lobe lesions in seven patients. A non-targeted biopsy was performed in 14
patients (7.8%), and a biopsy specimen was obtained from the right lobe in all those cases. 
The majority of patients were referred from service lines within the institution. Seventy-seven
patients (43.2%) were referred from outpatient services and 52 (29.2%) from inpatient services.
Forty-nine patients (27.5%) were referred from outside clinics. 
On radiology request forms for biopsy, adequate clinical information was provided in 177 (99%)
patients. In one patient, the field for clinical information on the radiology request form was left
blank.
Both 18 gauge (G) and 16 G needles were used for biopsy. An 18 G needle was used in 109
(61.2%) procedures and a 16 G in 69 (38.7%) procedures.
Based on the biopsy specimen, a final histopathological diagnosis was reached in 170 patients
(95%). A sampling error was noted in one patient (0.56%), resulting in a repeat biopsy.
Histopathological findings were inconclusive in one patient (0.56%). The histopathology
records of four patients (2.2%) were not available. The biopsy specimens of two patients (1.1%)
were sent to outside institutions and these records were not available. 
The audit standards set were met for all parameters, except for significant haemorrhage, in
which the target was narrowly missed (Table 5).
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Compliance with Audit Standards
Parameter Target (%) Rate achieved (%)* Was target met?
Completed consent form 100 100 (178/178) Yes
Post-procedural instructions 100 100 (178/178) Yes
Specimen adequacy > 98 99 (171/172) Yes
Minor pain < 30 1.1 (2/178) Yes
Severe pain < 3 0% (0/178) Yes
Significant hemorrhage < 0.5 0.56 (1/178) No
Vasovagal hypotension < 3 0.56 (1/178) Yes
Puncture of another organ < 0.1 0% (0/178) Yes
Hemobilia < 0.1 0% (0/178) Yes
Death < 0.1 0% (0/178) Yes
TABLE 5: Compliance with Audit Standards
Discussion
In this study, records of 178 patients were retrospectively evaluated for complications of
ultrasound-guided liver biopsy. Liver biopsy is an invasive procedure with associated risks that
must be weighed against the benefit of obtaining histology. The rate of complications must be
minimized to acceptable safety margins [5].
In our department, all liver biopsy procedures are performed with image guidance by
experienced radiologists. This is safer than image-assisted liver biopsy in which the biopsy site
is pre-marked without real-time needle visualization during the procedure. Audit
standards set for procedural aspects, diagnostic adequacy, and minor complications were met.
Audit standards were also met for major complications, except for significant hemorrhage in
which it was narrowly missed. No death was reported after the liver biopsy in our study. 
Overall complications occurred in nine patients (5%); seven complications (3.9%) were minor
and two complications (1.1%) were major. In patients who developed major complications,
one patient had a significant hemorrhage (> 2g/dL drop in hemoglobin) and another developed
severe hypotension.
The patient with major hemorrhage had been referred from an outside clinic. He had a
diagnosis of adenocarcinoma of the lung with Stage IV disease. His pre-procedure platelet
count was 34 × 109/ L, and he had received platelet transfusions prior to biopsy. A repeat
platelet count after transfusion had not been obtained. The international normalized ratio
(INR) checked more than one week before the biopsy was > 1.5, which had been corrected one
day prior to the procedure. The underlying deranged coagulation profile may have contributed
to the adverse outcome seen in this patient. The immediate post-biopsy focused assessment
with sonography for trauma (FAST) examination was positive in this patient; however, the
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patient was discharged as free fluid was mild and the amount remained unchanged over serial
FAST examinations. The patient presented in the emergency room (ER) two hours after
discharge with severe hypotension and Type I respiratory failure. There was a drop in the
hemoglobin from 12 mg/dL pre-procedure to 7.4 mg/dL post-procedure. A computed
tomography (CT) scan revealed hemorrhagic intraperitoneal free fluid in the perihepatic and
perisplenic regions. The patient was managed conservatively, received intravenous fluids in the
ER, and was admitted. He was discharged after 12 days in stable condition. The patient
presented in the ER again three months later with severe respiratory distress and expired due
to a massive pulmonary embolism.
Another patient with a major complication was an inpatient who developed severe hypotension
after the biopsy. The INR and platelet counts were within normal limits. A CT scan revealed a
small perihepatic hematoma and mild ascites. This patient was also managed conservatively
and was later discharged in stable condition. 
A baseline of INR ≤ 1.5 and platelet count ≥ 75 × 109/ L is required for all invasive procedures as
per departmental protocol. The INR and platelet counts of all patients were checked within the
same week.
The complication rate did not increase when the biopsy was performed with a larger needle
size. When a 16 G needle was used, complications occurred in two patients (2.8%). In contrast,
complications occurred in seven patients (6.4%) when an 18 G needle was used. This is
interesting as a larger needle size is usually associated with a higher risk of bleeding [8]. The
slightly higher complication rate for an 18 G needle may be explained by its relatively more
frequent use.
Conclusions
US-guided liver biopsy performed at our institution has a good safety profile with low
complication rates. Departmental policies and practices are compliant with
established guidelines.
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